OPIANT PHARMACEUTICALS, INC. Annual Operating Income (Loss) in USD from 2011 to 2021

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Opiant Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2021.
  • Opiant Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$9.63M, a 343% decline year-over-year.
  • Opiant Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$31.5M, a 1199% decline year-over-year.
  • Opiant Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was $5.16M.
  • Opiant Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$2.24M, a 121% decline from 2019.
  • Opiant Pharmaceuticals, Inc. annual Operating Income (Loss) for 2019 was $10.9M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $5.16M +$7.4M Jan 1, 2021 Dec 31, 2021 10-K 2022-03-15
2020 -$2.24M -$13.2M -121% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $10.9M +$32.1M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 -$21.2M -$19.3M -1029% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-04
2017 -$1.88M +$5.86M +75.7% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-21
2016 -$7.74M -$839K -12.2% Aug 1, 2015 Jul 31, 2016 10-KT 2018-03-07
2015 -$6.9M +$4.4M +39% Aug 1, 2014 Jul 31, 2015 10-K 2016-10-28
2014 -$11.3M -$2.5M -28.4% Aug 1, 2013 Jul 31, 2014 10-K 2015-10-26
2013 -$8.81M +$3.53M +28.6% Aug 1, 2012 Jul 31, 2013 10-K 2014-10-27
2012 -$12.3M -$2.9M -30.7% Aug 1, 2011 Jul 31, 2012 10-K 2013-10-29
2011 -$9.44M Aug 1, 2010 Jul 31, 2011 10-K/A 2012-11-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.